2H or 3H-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof

Details for Australian Patent Application No. 2005251982 (hide)

Owner Sanofi-Aventis

Inventors Evanno, Yannick; Maloizel, Christian; Sevrin, Mireille; Dubois, Laurent

Agent Davies Collison Cave

Pub. Number AU-B-2005251982

PCT Pub. Number WO2005/121099

Priority 0405055 11.05.04 FR

Filing date 10 May 2005

Wipo publication date 22 December 2005

Acceptance publication date 28 April 2011

International Classifications

C07D 231/54 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/121099 Priority application(s): WO2005/121099

28 April 2011 Application Accepted

  Published as AU-B-2005251982

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251983-Method for producing fabricated parts based on $G(B)-SiC for using in aggressive media

2005251979-LXR receptor modulators